All Title Author
Keywords Abstract

PLOS ONE  2013 

Globalization of Stem Cell Science: An Examination of Current and Past Collaborative Research Networks

DOI: 10.1371/journal.pone.0073598

Full-Text   Cite this paper   Add to My Lib

Abstract:

Science and engineering research has becoming an increasingly international phenomenon. Traditional bibliometric studies have not captured the evolution of collaborative partnerships between countries, particularly in emerging technologies such as stem cell science, in which an immense amount of investment has been made in the past decade. Analyzing over 2,800 articles from the top journals that include stem cell research in their publications, this study demonstrates the globalization of stem cell science. From 2000 to 2010, international collaborations increased from 20.9% to 36% of all stem cell publications analyzed. The United States remains the most prolific and the most dominant country in the field in terms of publications in high impact journals. But Asian countries, particularly China are steadily gaining ground. Exhibiting the largest relative growth, the percent of Chinese-authored stem cell papers grew more than ten-fold, while the percent of Chinese-authored international papers increased over seven times from 2000 to 2010. And while the percent of total stem cell publications exhibited modest growth for European countries, the percent of international publications increased more substantially, particularly in the United Kingdom. Overall, the data indicated that traditional networks of collaboration extant in 2000 still predominate in stem cell science. Although more nations are becoming involved in international collaborations and undertaking stem cell research, many of these efforts, with the exception of those in certain Asian countries, have yet to translate into publications in high impact journals.

References

[1]  US National Science Foundation (2012) Academic Research and Development. In: Science and Engineering Indicators 2012. National Science Foundation. Appendix 5–41.
[2]  Narin F, Stevens K, Whitlow E (1991) Scientific co-operation in Europe and the citation of multinationally authored papers. Scientometrics 21: 313–323.
[3]  Katz S, Hicks D (1997) How much is a collaboration worth? A calibrated bibliometric model. Scientometrics 40: 541–554.
[4]  Goldfinch S, Dale T, DeRouen K (2003) Science from the periphery: collaboration, networks, and periphery effects in the citation of New Zealand Crown Research Institutes articles, 1995–2000. Scientometrics 57: 321–337.
[5]  Gl?nzel W, Schubert A (2005) Domesticity and internationality in co-authorship, references and citations. Scientometrics 65: 323–342.
[6]  Luo J, Flynn JM, Solnick RE, Ecklund EH, Matthews KRW (2011) International stem cell collaboration: how disparate policies between the United States and the United Kingdom impact research. PLoS ONE 6: e17684. Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0017684. Accessed 2013 Aug 1.
[7]  Flynn JM, Matthews KRW (2010) Stem cell research in the Greater Middle East: the importance of establishing policy and ethics interoperability to foster international collaborations. Stem Cell Rev and Rep 6: 143–150.
[8]  Price DS (1986). Little Science, Big Science…and Beyond. New York, NY: Columbia University Press.
[9]  Katz JS (1994) Geographic proximity and scientific collaboration. Scientometrics 31: 31–43.
[10]  Luukkonen T, Persson O, Sivertsen G (1992) Understanding patterns of international scientific collaboration. Science, Technology, and Human Values 17: 101–126.
[11]  US National Science Foundation (2010) Globalization of Science and Engineering Research. In: Science and Engineering Indicators 2010. National Science Foundation. Science and Engineering Indicators Companion.
[12]  Li L, Ding G, Feng N, Wang M, Ho Y (2009) Global stem cell research trend: bibliometric analysis as a tool for mapping of trends from 1991 to 2006. Scientometrics 80: 39–58.
[13]  Newman MEJ (2004) Coauthorship networks and patterns of scientific collaboration. PNAS 101: 5200–5205.
[14]  Wallace ML, Larivière V, Gingras Y (2012) A small world of citations? The influence of collaboration networks on citation practices. PLoS One 7: e33339.Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0033339. Accessed 2013 Aug 1.
[15]  US National Institutes of Health (2009) Stem cell basics: what are stem cells, and why are they important. Available: http://stemcells.nih.gov/info/basics. Accessed 2013 Aug 1.
[16]  Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 1–12.
[17]  Ben-David U, Kopper O, Benvenist N (2012) Expanding the Boundaries of Embryonic Stem Cell Research. Cell Stem Cell 10: 666–677.
[18]  CNN (2001) President George W. Bush’s address on stem cell research. CNN Politics Transcript. Available: http://edition.cnn.com/2001/ALLPOLITICS/?08/09/bush.transcript/index.html. Accessed 2012 Apr 26.
[19]  Obama B (2009) Executive order 13505: Removing barriers to responsible scientific research involving human stem cells. Federal Register 74: 10667–10668.
[20]  Human Fertilization and Embryology Authority (1990) The human fertilization and embryology act of 1990. Available: http://www.hfea.gov.uk/2070.html. Accessed 2011 Dec 8.
[21]  Widermann P, Simon J, Schichtanz S, Tannert C (2004) The future of stem cell in Germany. EMBO Reports 5: 927–931.
[22]  Herrmann I, Woopen C, Brüstle O (2008) Germany parliament passes amendment to Stem Cell Act. Eurostemcell. Available: http://www.eurostemcell.org/commentanaly?sis/german-parliament-passes-amendment-s?tem-cell-act. Accessed 2012 Aug 4.
[23]  Matthews KRW (2009) Stem cell research: a science and policy overview. Baker Institute for Public Policy Report. Available: http://www.bakerinstitute.org/publicatio?ns/stemcell-intro-0208.pdf. Accessed 2011 Dec 8.
[24]  Liao LM, Li LS, Zhao RC (2007) Stem cell research in China. Philosophical Transactions of the Royal Society B: Biological Sciences. 362: 1107–1112.
[25]  Cyranoski D (2012) China’s stem-cell rules go unheeded. Nature News. Available at: http://www.nature.com/news/china-s-stem-?cell-rules-go-unheeded-1.10410. Accessed 2013 Jun 7.
[26]  Ho YS, Chiu CH, Tseng TM, Chiu WT (2003) Assessing stem cell research productivity.”. Scientometrics 57: 369–376.
[27]  Carlstein S (2010) Databases for bibliometric analysis. J?nk?ping University. Available: http://hj.se/bibl/en/publishing/bibliome?trics/databases-for-bibliometric-analysi?s.html. Accessed 2012 Apr 25.
[28]  Thomson J, Itskovitz-Eldor J, Shapiro S, Waknitz M, Swiergiel J, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
[29]  Amin M, Mabel M (2000) Impact factors: use and abuse. Perspectives in Publishing. Available: http://www.elsevier.com/framework_editor?s/pdfs/Perspectives1.pdf. Accessed 2012 Apr 24.
[30]  Garfield E (1994) The Thomson Reuters Impact Factor. Available: http://thomsonreuters.com/products_servi?ces/science/free/essays/impact_factor/. Accessed 2012 Apr 25.
[31]  Abt H (1984) Citations to single and multiauthored papers. Publication of the Astronomical Society of the Pacific. 96: 746–749.
[32]  Smart J, Bayer A (1986) Author collaboration and impact: a note on citation rates of single and multiple authored articles. Scientometrics 10: 297–305.
[33]  Herbertz H (1995) Does it pay to cooperate? A bibliometric case study in molecular biology. Scientometrics 33: 117–122.
[34]  Gl?nzel W (2002) Coauthorship patterns and trends in the sciences (1980–1998): a bibliometric study with implications for database indexing and search strategies. Library Trends. 50: 461–473.
[35]  US National Institutes of Health (2010) Stem Cells and Diseases. Available: http://stemcells.nih.gov/info/basics/bas?ics6.asp. Accessed 2011 Dec 5.
[36]  US National Science Foundation (2012) R&D: National Trends and International Comparisons. In: Science and Engineering Indicators 2012. National Science Foundation.
[37]  Doring O (2003) China’s struggle for practical regulations in medical ethics. Nat Rev Genet 4: 233–239.
[38]  McMahon D, Thorsteinsdóttir H, Singer PA, Daar A (2010) Cultivating regenerative medicine innovation in China. Reg Med 10: 35–44.
[39]  Salter B, Cooper M, Dickins A (2006) China and the global stem cell bioeconomy: an emerging political strategy? Regen Med 1: 671–783.
[40]  Doring O (2004) Chinese researchers promote biomedical regulations: what are the motives of the biopolitical dawn in China and where are they heading? Kennedy Instit Ethics J. 14: 39–46.
[41]  Ministry of Health of the People’s Republic of China (2009) Clinical application of technology management approach. Available: http://www.moh.gov.cn/publicfiles/busine?ss/htmlfiles/mohyzs/s3585/200903/39511.h?tm. Accessed 2012 Jul 29.
[42]  US National Science Foundation (2012) Academic Research and Development. In: Science and Engineering Indicators 2012. National Science Foundation.
[43]  Zweig D, Wang H (2012) Can China bring back the best? The Communist Party organizes China’s search for talent. China Quarterly. Available: http://www.google.com/url?sa=t&rct=j&q=&?esrc=s&source=web&cd=1&cad=rja&ved=0CCwQ?FjAA&url=http%3A%2F%2Fwww.sosc.ust.hk%2F?community_corner%2Fpdf%2FDavid%2520Zweig?%2520Working%2520Paper%2520May%25202012.?pdf&ei=f436UZ6wNZCe9QTQvoDABA&usg=AFQjCN?Ghti66-TN0qEXvGBv2SWITJbpJwg&bvm=bv.5016?5853,d.eWU. Accessed 2013 Aug 1.
[44]  European Commission (2002) Work Programme – specific extract for Thematic Priority 1: life sciences, genomics and biotechnology for health. Available: ftp://ftp.cordis.europa.eu/pub/fp6/docs/?wp/sp1/a_wp_200201_en.pdf. Accessed 2012 Aug 2.
[45]  European Commission (2005) Proposal for a council decision concerning the specific programme cooperation implementing the seventh framework programme. (2007–2013): 440.
[46]  United Kingdom Human Tissue Authority (2008) Stem cell science in the UK: key facts about research, regulation, and funders. Available: http://www.hta.gov.uk/_db/_documents/ste?m_cell_pack_200806170144.pdf.
[47]  International Stem Cell Banking Initiative (2009) Consensus guidance for banking and supply of human embryonic stem cell lines for research purposes. Stem Cell Rev and Rep 5: 301–314.
[48]  Tansey B (2008) State, United Kingdom team for stem cell work. San Francisco Chronicle. Available: http://www.sfgate.com/business/article/S?tate-United-Kingdom-team-for-stem-cell-w?ork-3264981.php. Accessed 2013 Jun 7.
[49]  Isasi RM, Knoppers BM (2006) Beyond the permissibility of embryonic and stem cell research: substantive requirements and procedural safeguards. Hum Reprod 21: 2474–2481.
[50]  Schuldt BM, Guhr A, Lenz M, Kobold S, MacArthur BD, et al.. (2013) Power-laws and the use of pluripotent stem cell lines. PLoS ONE 8(1): e52068.Available: http://www.plosone.org/article/info%3Ado?i%2F10.1371%2Fjournal.pone.0052068 Accessed 2013 Aug 1.
[51]  L?ser P, Schirm J, Guhr A, Wobuse AM, Kurtz A (2009) Human embryonic stem cell lines and their use in international research. Stem Cells 28: 240–46.

Full-Text

comments powered by Disqus